Text Size
Donate

Glaucoma Research Foundation Hosts Innovations in Glaucoma Forum at the Harvard Club of New York City

L-R: Thomas Brunner, C. Seth Cunningham, Dr. Martin Wax, and Dr. Andrew Prince
L-R: Thomas Brunner, C. Seth Cunningham, Dr. Martin Wax, and Dr. Andrew Prince

Glaucoma Research Foundation (GRF) hosted the Innovations in Glaucoma Forum at the Harvard Club of New York City on May 18th in collaboration with GRF Council member Andrew Prince, MD, former GRF Board member C. Seth Cunningham, and current GRF Board member Rick Halprin.

The reception and lecture welcomed more than 100 guests including many members of the New York Eye and Ear Infirmary’s Glaucoma Support and Education Group.

2017-nyc-02-wax_290.jpg

Dr. Wax presenting his lecture

Featured speaker Martin B. Wax, MD presented his lecture “A Glaucoma Timeline: Past, Present, and Future” and discussed the stages of glaucoma from identification of the disease to its progression, and highlighted the importance of new glaucoma biomarkers to aid in more effective diagnosis and treatments for patients. Dr. Wax also mentioned the role that the Glaucoma Research Foundation has taken by forming and funding the Catalyst for a Cure collaborative research teams, whose ongoing efforts continue to lead initiatives in the search for a cure for glaucoma.

Dr. Wax is Clinical Professor of Ophthalmology at New York University Langone Medical Center, and Chief Medical Officer and Executive Vice President of Research and Development at PanOptica, Inc. Dr. Wax has served on the GRF Board of Directors and the Catalyst for a Cure Advisory Board since 2003, and is a member of the Board’s Research Committee.

2017-nyc-03-tmb_290.jpg

Thomas M. Brunner (left) with GRF donor and guest Alan G. Weiler

Thomas M. Brunner, GRF President and CEO, concluded the talk with information to guests on The Cure is in Sight Campaign for Glaucoma Research Foundation and its ambitious goal to raise $15 million by June 2018, to coincide with the Foundation’s 40th anniversary. Mr. Brunner reported that, thanks to early participation from donors, more than $10 million has already been raised towards the Campaign goal. Further, Mr. Brunner announced the new Campaign website that allows anyone to create their own fundraising page and share their personal campaign through email and social media.

To learn more about creating your own fundraising page or to make a donation to The Cure is in Sight Campaign, please visit www.glaucoma.org/campaign.

Read more about the Catalyst for a Cure research collaboration »

See photos from the 2017 Innovations in Glaucoma Forum »

Last reviewed on June 07, 2017

Was this helpful? Yes No